GlassScriptPhysician profile
Nicholas Robert Metrus
NPI 1356785067
$49,071.94
in general payments reported to CMS, 2019-2025
16 companies · $6,956 in 2025
The $6,956 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $481 · 2021: $253 · 2022: $9,468 · 2023: $28K · 2024: $3,424 · 2025: $6,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $34K · Food and Beverage: $2,850 · Honoraria: $1,000 · Travel and Lodging: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $33,600.00 |
| Food and Beverage | $2,849.85 |
| Honoraria | $1,000.00 |
| Travel and Lodging | $944.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $48,175.07 | 2019-2025 | Optune, Optune Gio |
| Telix Pharmaceuticals | $189.85 | 2025 | Illuccix |
| Teva Pharmaceuticals USA, INC. | $139.82 | 2019 | |
| Ucb, INC. | $137.54 | 2019 | |
| Servier Pharmaceuticals LLC | $109.30 | 2024-2025 | |
| Aucta Pharmaceuticals, INC. | $93.61 | 2025 | Motpoly Xr |
| Eisai INC. | $63.28 | 2019-2020 | |
| Janssen Biotech, INC. | $35.59 | 2023-2024 | Imbruvica, Tecvayli, Darzalex |
| Springworks Therapeutics, INC. | $23.48 | 2025 | Gomekli |
| Pharmacosmos Therapeutics INC. | $16.59 | 2023 | Monoferric |
| Pfizer INC. | $16.43 | 2024 | |
| Caris Mpi, INC. | $15.98 | 2025 | Mi Cancer Seek |
| Amgen INC. | $15.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.35 | 2019 | |
| Kyowa Kirin, INC. | $13.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $12.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Metrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.